Close

UBS Prefers MetLife (MET) Over Prudential (PRU)

August 23, 2012 1:21 PM EDT
Get Alerts MET Hot Sheet
Price: $72.22 +0.36%

Rating Summary:
    18 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
UBS analyst Suneet Kamath prefers MetLife (NYSE: MET) over Prudential (NYSE: PRU).

On July 18th, 2012, UBS initiated coverage on MetLife with a Buy rating.

Kamath believes that investors concerns were around the timing and size of capital returns (citing regulatory uncertainty). MET’s long-term ROE guidance may prove conservative, providing a potential upside surprise. Also, since MET acquired Alico, Kamath, views MET as the only true global play in their coverage universe.

On the same day, Kamath also initiated coverage on Prudential, but with a Neutral rating.

Kamath believed that PRU would run into challenges trying to reach its goal of 13% ROE. The company's business model is attractive, but at this point, MET is the preferred stock between the two.

Over the past month, both shares are trading higher, PRU up 17%, MET up 21%.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

UBS